nasopharyng
carcinoma
npc
squamou
cell
carcinoma
rise
post
nasal
caviti
preval
southern
china
southeastern
asia
taiwan
worldwid
approxim
case
npc
report
year
cancer
gener
surviv
rate
npc
treatment
begin
earli
stage
surviv
rate
reach
howev
poor
later
stage
npc
radiotherapi
primari
effect
treatment
npc
combin
radiotherapi
neoadjuv
chemotherapi
anoth
pivot
treatment
npc
patient
increas
surviv
rate
significantli
although
therapeut
effici
npc
manag
larg
improv
avoid
npc
metastasi
still
urgent
unmet
need
genet
environment
viral
factor
incrimin
etiolog
npc
epsteinbarr
viru
ebv
strongli
associ
occurr
npc
ebv
member
gamma
herpesvirus
kb
doublestrand
dna
genom
life
cycl
ebv
includ
latenc
lytic
replic
eleven
gene
product
ebna
lmp
small
rna
eber
express
latent
infect
upon
induct
chemic
stress
ebv
activ
enter
lytic
cycl
known
reactiv
three
subset
lytic
gene
immediateearli
earli
late
gene
express
sequenti
subsequ
viral
particl
packag
releas
year
studi
ebv
latent
infect
consid
play
import
role
npc
carcinogenesi
recent
year
accumul
evid
suggest
ebv
lytic
infect
also
contribut
tumorigenesi
npc
seroepidemiolog
survey
indic
patient
elev
antibodi
titer
ebv
lytic
protein
viral
capsid
antigen
vca
dnase
dna
polymeras
earli
antigen
ea
high
risk
npc
sever
ebv
lytic
product
detect
npc
biopsi
addit
ebv
lytic
protein
includ
dnase
shown
variou
tumorigen
function
previou
studi
found
ebv
reactiv
chemic
promot
cellular
genom
instabl
tumor
growth
collect
report
suggest
inhibit
ebv
reactiv
might
use
npc
prevent
therapi
accordingli
safeti
conveni
screen
sever
dietari
compound
antiebv
activ
report
flavonoid
activ
ebv
reactiv
inhibit
ebv
npc
tumorigenesi
repress
report
phytochem
emodin
potenti
abil
inhibit
ebv
reactiv
emodin
common
tradit
chines
medicin
anthraquinon
deriv
present
root
rhizom
rhubarb
emodin
variou
medic
applic
includ
anticanc
antioxid
antiinflamm
allergi
antidiabet
antivir
bacteri
activ
antivir
effect
emodin
abil
inhibit
sar
coronaviru
block
replic
hbv
coxsackieviru
zika
viru
influenza
viru
moreov
emodin
suggest
inhibit
replic
herpesvirus
howev
detail
mechan
well
elucid
studi
base
screen
show
emodin
inhibit
ebv
reactiv
epitheli
cell
mechan
repress
express
inhibit
zta
rta
promot
activ
moreov
antiebv
activ
npc
tumorigenesi
could
reliev
suggest
emodin
potenti
agent
therapi
ebvassoci
cancer
emodin
figur
shown
cytotox
human
cell
line
investig
antiebv
effect
emodin
two
ebvposit
npc
cell
line
na
ha
parent
cell
assess
suscept
cytotox
emodin
cell
seed
plate
h
prior
treatment
emodin
ad
h
determin
cytotox
effect
npc
cell
line
na
ha
emodin
signific
toxic
cell
deriv
na
cell
show
littl
resist
compound
figur
similar
effect
seen
ha
cell
figur
furthermor
evalu
result
precis
half
maximum
cytotox
concentr
calcul
shown
top
panel
figur
valu
deriv
na
cell
line
valu
ha
respect
figur
impli
cell
harbor
ebv
seem
resist
emodin
vs
na
p
vs
ha
p
base
result
chose
emodin
work
concentr
studi
hand
ebv
lytic
replic
effici
induc
treat
na
ha
cell
ngml
tpa
plu
mm
sodium
butyr
sb
tpasb
h
determin
whether
emodin
effect
ebv
reactiv
prior
tpasb
induct
cell
expos
variou
concentr
emodin
h
follow
western
blot
analysi
ebv
lytic
protein
zta
rta
ead
dnase
shown
figur
lytic
protein
express
induc
emodin
alon
na
ha
cell
left
panel
howev
cell
cotreat
emodin
express
lytic
protein
decreas
dosedepend
manner
suggest
emodin
abil
inhibit
ebv
reactiv
npc
cell
right
panel
confirm
inhibitori
effect
emodin
ebv
popul
cell
express
ead
marker
ebv
reactiv
detect
immunofluoresc
stain
monitor
inhibit
reactiv
emodin
emodin
could
induc
ead
express
na
ha
cell
line
howev
popul
eadexpress
na
figur
ha
figur
cell
decreas
gradual
follow
treatment
increas
concentr
emodin
emodin
repress
number
eadexpress
na
ha
cell
moder
dose
significantli
complet
blockag
quantifi
chang
proport
eadposit
cell
flow
cytometri
ebv
induct
follow
emodin
treatment
h
induct
tpa
sb
percentag
eadposit
na
cell
reduc
treatment
emodin
respect
figur
meantim
ha
cell
express
ead
tpa
sb
induct
figur
lower
na
cell
proport
eadexpress
ha
cell
follow
treatment
emodin
respect
figur
result
give
anoth
evid
support
hypothesi
emodin
inhibit
ebv
lytic
cycl
demonstr
emodin
block
express
ebv
lytic
protein
question
rais
emodin
inhibit
ebv
lytic
cycl
complet
solv
issu
npc
cell
pretreat
emodin
h
follow
tpa
sb
treatment
incub
h
amount
releas
eb
virion
measur
supernat
emodin
abil
inhibit
virion
product
ebv
dosedepend
manner
na
figur
ha
figur
cell
taken
togeth
result
indic
emodin
repress
ebv
lytic
protein
express
attenu
virion
product
clearli
suggest
abil
inhibit
ebv
reactiv
zta
rta
two
import
immediateearli
ie
protein
involv
initi
ebv
lytic
reactiv
access
whether
emodin
exert
antiebv
activ
interf
ie
gene
promot
luciferas
report
assay
perform
detect
promot
activ
zp
rp
respect
presenc
absenc
emodin
ebvposit
na
neg
npc
cell
use
studi
shown
figur
b
tpasb
significantli
increas
zp
rp
activ
na
cell
addit
emodin
decreas
promot
activ
dosedepend
manner
note
promot
activ
detect
na
cell
higher
cell
ebv
harbor
na
cell
creat
autocrin
regul
amplifi
zp
rp
activ
simul
next
addit
tpa
sb
ask
whether
emodin
also
inhibit
zta
rta
mediat
ebv
reactiv
end
zta
rtaexpress
plasmid
cotransfect
zp
rp
report
plasmid
respect
follow
emodin
treatment
h
expect
ectop
zta
activ
zp
rp
wherea
cotreat
emodin
significantli
reduc
promot
activ
dosedepend
manner
figur
similarli
overexpress
rta
result
zp
rp
activ
addit
emodin
revers
phenomenon
figur
f
thu
result
suggest
emodin
abl
inhibit
chemic
ztartainduc
ebv
lytic
reactiv
via
repress
ie
gene
promot
activ
zta
first
protein
express
ebv
lytic
cycl
wish
know
element
zp
essenti
emodin
inhibit
end
luciferasereport
plasmid
driven
seri
delet
mutant
zp
construct
mutant
respect
transfect
cell
follow
aforement
compound
treatment
luciferasereport
assay
depict
figur
compar
wild
type
promot
retain
half
activ
promot
shorter
region
gradual
lose
respons
tpasb
notabl
inhibit
zp
activ
emodin
also
show
similar
pattern
indic
element
requir
emodin
inhibit
resid
region
two
major
domain
locat
within
region
zii
known
involv
regul
zii
contain
sever
transcript
factor
bind
site
import
zp
activ
includ
creb
determin
regulatori
factor
import
emodin
inhibit
four
zp
construct
mutat
zii
domain
design
respect
use
compound
treatment
luciferasereport
assay
mention
shown
figur
emodin
inhibit
phenomenon
compromis
significantli
wherea
activ
maintain
similar
level
wildtyp
control
among
inhibit
fold
display
signific
alter
attract
attent
sought
determin
whether
emodin
affect
express
shown
figur
express
repress
emodin
dosedepend
manner
without
tpasb
cotreat
impli
emodin
inhibit
zp
activ
repress
express
final
sought
identifi
whether
emodinelicit
zp
inhibit
mediat
repress
transfect
plasmid
resuppli
protein
level
emodin
treatment
determin
whether
zp
activ
compens
result
reveal
tpasbactiv
zp
activ
repress
emodin
significantli
figur
left
panel
howev
repress
compens
gradual
resuppli
figur
right
panel
sum
result
suggest
emodin
inhibit
ebv
reactiv
repress
previous
show
recurr
ebv
reactiv
lead
profound
genom
instabl
npc
tumorigenesi
importantli
effect
would
prevent
ebv
reactiv
could
block
test
whether
emodin
inhibit
ebv
reactivationinduc
tumorigen
properti
cell
cultur
model
repeat
ebv
reactiv
combin
emodin
treatment
use
examin
impact
emodin
reactivationinduc
malign
characterist
na
cell
first
repeat
tsinduc
na
cell
without
emodin
treatment
subject
micronucleu
mn
format
assay
expect
observ
emodin
affect
doesdepend
decreas
mn
format
promin
featur
associ
ebv
reactiv
figur
next
sinc
ebv
reactiv
implic
sever
tumorigen
properti
npc
cell
includ
cell
prolifer
cell
migrat
cell
invas
sought
determin
whether
emodin
suppress
malign
properti
induc
recurr
ebv
reactiv
shown
figur
increas
cell
prolifer
observ
tstreat
group
increas
gradual
reduc
emodin
treatment
similarli
cell
migrat
figur
cell
invas
figur
tstreat
na
significantli
repress
emodin
treatment
reinforc
notion
emodin
capabl
suppress
variou
malign
featur
na
cell
impos
recurr
ebv
reactiv
access
effect
emodin
ebv
reactiv
vivo
two
million
na
cell
subcutan
inocul
dorsal
bodi
scid
mice
previou
studi
found
toxic
administr
tpa
plu
sb
mice
sole
sb
treatment
less
toxic
enough
reactiv
ebv
harbor
na
cell
mice
approxim
week
later
tumor
size
reach
cm
mice
randomli
assign
four
group
mock
emodin
sb
sbemodin
compound
intraperiton
administ
mice
everi
day
figur
note
mgkg
sb
suffici
reactiv
ebv
lytic
cycl
toxic
effect
vivo
figur
two
week
tumor
harvest
weigh
analysi
sb
group
found
averag
tumor
size
increas
sb
treatment
compar
mock
control
figur
howev
increas
repress
emodin
administr
figur
meanwhil
tumor
size
emodin
group
similar
mock
control
figur
measur
tumor
weight
sb
group
also
heavier
control
group
howev
tumor
weight
lower
sbemodin
group
figur
taken
togeth
result
suggest
emodin
inhibitori
effect
tumor
growth
mous
model
via
inhibit
ebv
reactiv
npc
virusassoci
cancer
uniqu
geograph
racial
distribut
one
etiolog
agent
npc
ebv
mark
therapeut
target
long
time
larg
number
studi
focus
ebv
latent
protein
includ
present
time
effort
mani
scientist
lytic
cycl
ebv
gradual
unmask
understand
contribut
npc
tumorigenesi
know
variou
ebv
lytic
protein
make
differ
contribut
tumor
progress
eg
dnase
terminas
caus
genom
instabl
rta
induc
chromosom
aberr
exhibit
antiapoptot
effect
base
find
treat
ebv
reactiv
target
develop
anticanc
therapi
moreov
sever
clinic
trial
determin
whether
treatment
antiebv
compound
could
reliev
npc
tumorigenesi
progress
recent
antimicrobi
adjuv
therapi
becom
popular
treat
virusrel
cancer
cancerassoci
infect
ebv
lytic
replicationbas
therapi
attract
attent
cancer
therapi
two
treatment
strategi
develop
vigor
one
inhibit
ebv
reactiv
repress
tumor
growth
induct
ebv
reactiv
enabl
cytolyt
therapi
compar
latter
strategi
inhibit
ebv
lytic
cycl
least
three
benefit
anticanc
therapi
first
block
ebv
lytic
cycl
may
stop
cell
cell
transmiss
ebv
second
inhibit
ebv
reactiv
could
also
reduc
express
oncogen
lytic
protein
third
suppress
ebv
reactiv
attenu
oncogen
endocrin
factor
releas
ebv
enter
lytic
cycl
advantag
led
massiv
search
new
compound
activ
ebv
lytic
replic
mani
small
molecul
found
effect
suppress
ebv
lytic
reactiv
especi
natur
compound
among
famili
polyphenol
egcg
attract
attent
antiebv
activ
shown
inhibit
ebv
reactiv
repress
pathway
curcumin
found
inhibit
ebv
reactiv
interfer
gene
transcript
resveratrol
found
antiebv
activ
suppress
activ
transcript
factor
sulforaphan
antiebv
agent
reduc
transactiv
activ
rta
protein
among
famili
flavonoid
luteolin
shown
inhibit
ebv
reactiv
interf
bind
zp
rp
repress
tumor
growth
mous
model
genistein
antiebv
activ
block
activ
iggmedi
tyrosin
kinas
protoapigenon
act
ebv
reduc
zta
transcript
activ
addit
two
major
famili
natur
compound
andrographolid
moron
acid
also
report
inhibit
ie
protein
express
antiebv
activ
bcell
system
interestingli
compound
found
bcell
system
cellular
environ
may
differ
epitheli
cell
may
less
effect
epitheli
cell
system
fact
ebv
prefer
remain
latent
b
cell
progress
lytic
stage
epitheli
cell
thu
laboratori
make
effort
search
epitheli
cell
system
natur
antiebv
compound
npc
therapi
preliminari
screen
found
sever
compound
antiebv
activ
report
studi
report
anoth
compound
emodin
found
screen
potenti
antiebv
activ
carri
immunoblot
figur
immunofluoresc
assay
figur
b
flow
cytometr
analysi
figur
show
emodin
treatment
inhibit
express
ebv
lytic
protein
also
demonstr
emodin
decreas
eb
virion
product
npc
cell
line
experi
indic
emodin
repress
promot
activ
zp
rp
figur
dissect
underli
mechan
zii
domain
shown
involv
zp
inhibit
emodin
may
downregul
express
figur
final
show
administr
emodin
restrain
reactivationinduc
tumorigen
properti
repress
tumor
growth
mous
model
result
suggest
emodin
potenti
ebvbas
npc
therapi
anoth
aspect
emodin
also
show
good
potenti
antiebv
therapi
epitheli
figur
b
cell
system
also
show
emodin
repress
express
epitheli
cell
consist
report
known
bind
crucial
activ
sever
virus
fact
virus
shown
inactiv
emodin
impli
wide
inhibitori
spectrum
although
demonstr
emodin
inhibit
ebv
reactiv
interf
express
rais
question
emodin
affect
express
wellknown
express
highli
depend
cell
cycl
regul
transcript
affect
sever
pathway
includ
amount
protein
dna
bind
activ
transactiv
activ
analyz
composit
promot
regul
express
shown
depend
rel
amount
nfi
protein
cell
nucleu
emodin
abl
inhibit
express
accordingli
one
possibl
mechan
emodin
inhibit
express
inhibit
express
moreov
overexpress
also
found
decreas
mrna
emodin
abl
upregul
protein
level
arrest
cell
cycl
induc
apoptosi
henc
emodin
treatment
may
inhibit
express
upregul
addit
might
also
reason
postul
emodin
may
interfer
express
via
antioxid
activ
upregul
cell
oxid
stress
summari
repress
reactivationinduc
tumorigenesi
find
effici
compound
ebv
reactiv
import
issu
end
screen
found
emodin
possess
antiebv
activ
util
repress
tumor
growth
vitro
vivo
studi
give
new
insight
applic
emodin
hope
may
provid
altern
choic
antivir
therapi
cancer
prevent
chemic
use
studi
includ
emodin
tpa
sodium
butyr
sb
purchas
sigmaaldrich
co
st
loui
mo
usa
ebv
antibodi
use
studi
follow
antiebv
zta
antiebv
rta
unpublish
ead
antidnas
antigapdh
sigmaaldrich
co
npc
cell
line
kind
gift
dr
ct
lin
dr
r
glaser
respect
na
ha
ebvinfect
npc
cell
line
obtain
cocultur
rakata
cell
npc
cell
respect
select
treatment
npc
cell
line
maintain
dmem
dulbecco
modifi
eagl
medium
fetal
calf
serum
fc
determin
whether
emodin
could
induc
ebv
reactiv
ebvposit
cell
line
na
ha
seed
h
treat
variou
amount
emodin
h
harvest
analysi
determin
whether
emodin
could
inhibit
ebv
reactiv
na
ha
cell
seed
h
induct
cell
pretreat
emodin
h
tpa
ngml
plu
sb
mm
ad
induc
ebv
reactiv
h
incub
cell
harvest
analysi
cytotox
emodin
cell
line
determin
assay
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
briefli
two
set
cell
line
includ
na
cell
cellswel
ha
cell
cellswel
seed
well
plate
cell
incub
variou
concentr
emodin
h
cytotox
measur
assay
fluoresc
determin
use
micropl
reader
infinit
tecan
switzerland
valu
half
maximum
cytotox
concentr
defin
concentr
emodin
kill
cell
mean
standard
deviat
calcul
least
three
independ
experi
cell
extract
separ
sdspage
transfer
hybondc
super
membran
amersham
bioscienc
ltd
littl
chalfont
uk
blot
first
incub
block
buffer
mm
trishcl
ph
nacl
skim
milk
h
react
antibodi
h
room
temperatur
wash
three
time
wash
buffer
mm
trishcl
ph
nacl
blot
incub
horseradish
peroxidaselabel
goat
antimous
igg
amersham
bioscienc
ltd
block
buffer
h
room
temperatur
incub
overnight
membran
wash
wash
buffer
develop
freshli
prepar
substrat
amersham
bioscienc
ltd
luminesc
detect
use
short
exposur
xray
film
origin
pictur
western
blot
found
supplementari
materi
figur
determin
number
cell
switch
lytic
cycl
immunofluoresc
flow
cytometri
analysi
carri
previou
studi
briefli
immunofluoresc
stain
treat
cell
fix
formaldehyd
solut
min
fix
cell
permeabil
triton
pb
min
wash
fc
pb
cell
block
fcspb
min
incub
antiead
antibodi
dilut
h
room
temperatur
secondari
antibodi
rhodamin
conjug
goat
antimous
igg
dilut
fcspb
ad
h
final
cell
wash
fcspb
observ
fluoresc
microscopi
nuclei
stain
dapi
sigmaaldrich
co
stain
flow
cytometr
analysi
treat
cell
harvest
immedi
fix
ethanol
fix
cell
permeabil
triton
fb
incub
antiead
antibodi
dilut
h
cell
wash
pb
incub
goat
antimous
igg
rhodamineconjug
antibodi
h
cell
wash
adjust
becton
dickinson
facscan
flow
cytomet
bd
bioscienc
san
jose
ca
usa
sampl
test
cell
detect
releas
ebv
particl
na
cell
cellswel
incub
tpa
ngml
sb
mm
h
pretreat
emodin
h
supernat
filter
filter
supernat
ml
incub
ml
dnase
dnase
buffer
mm
trishcl
mm
mm
ph
min
ml
mm
edta
ph
ad
termin
dnase
activ
sampl
treat
mgml
proteinas
k
sampl
proteinas
k
volvol
min
reaction
stop
inactiv
proteinas
k
activ
min
subsequ
sampl
examin
fragment
dna
polymeras
ebv
realtim
pcr
analysi
chen
et
al
sens
antisens
reaction
mixtur
contain
ml
prepar
viral
dna
sampl
ml
master
mix
kapa
biosystem
fast
qpcr
kit
ml
specif
primer
mm
pcrgrade
water
final
volum
ml
qpcr
condit
denatur
anneal
extens
primer
cycl
specif
pcr
reaction
control
melt
curv
analysi
lightcycl
roch
appli
scienc
indianapoli
usa
result
three
independ
experi
use
calcul
mean
standard
deviat
construct
zp
rp
report
plasmid
describ
previous
zta
rta
plasmid
report
transfect
use
lipofectamin
invitrogen
carlsbad
ca
usa
briefli
chemic
induct
na
cell
seed
number
per
well
zp
rp
plasmid
mix
lipofectamin
invitrogen
optimem
medium
invitrogen
incub
min
room
temperatur
ad
well
h
incub
emodin
ad
pretreat
h
tpa
ngml
plu
sb
mm
ad
induc
ebv
lytic
cycl
zta
rta
induct
zp
rp
cotransfect
ztaexpress
rtaexpress
plasmid
na
cell
respect
emodin
ad
h
transfect
induct
h
cell
lyse
hepe
buffer
hepe
ph
triton
mm
mm
lysat
ad
combin
luciferas
assay
reagent
ii
promega
corpor
madison
wi
usa
min
incub
final
luciferas
activ
detect
use
luminesc
counter
packard
instrument
compani
meriden
ct
usa
lysat
sampl
standard
express
control
variat
differ
sampl
mean
standard
deviat
sampl
calcul
three
independ
experi
duplic
detect
mn
format
perform
describ
previous
briefli
cell
repeat
treatment
induc
combin
without
emodin
seed
onto
coverslip
adher
h
incub
cultur
medium
remov
cell
wash
twice
pb
ph
cell
fix
icecold
methanol
immedi
min
wash
pb
cell
stain
dapi
sigmaaldrich
st
loui
mo
usa
min
micronuclei
monitor
use
fluoresc
microscop
olympu
tokyo
japan
cell
migrat
assay
carri
use
ori
system
platypu
technolog
platypu
technolog
madison
wi
usa
chiu
et
al
briefli
cell
seed
plate
ori
stopper
h
incub
stopper
remov
cell
incub
h
permit
cell
migrat
cell
subject
pi
stain
photograph
fluoresc
microscopi
olympu
tokyo
japan
closur
cellfre
zone
measur
imag
j
softwar
nation
institut
health
bethesda
md
usa
cell
migrat
shown
percentag
closur
calcul
use
follow
equat
premigr
area
migrat
area
premigr
area
mean
standard
deviat
sampl
calcul
three
independ
experi
cell
invas
assay
perform
use
ht
fluoroblok
insert
falcon
cambridg
usa
describ
previous
briefli
transwel
membran
coat
matrigel
becton
dickinson
franklin
lake
nj
usa
cell
seed
onto
matrigelco
membran
insert
fb
medium
insert
place
plate
fb
medium
h
incub
incub
membran
fix
methanol
stain
propidium
iodid
cell
invad
transmigr
lower
surfac
polycarbon
membran
photograph
use
fluoresc
microscop
cell
number
count
analyz
vivo
tumorigenesi
assay
scid
mice
sixweekold
inocul
subcutan
na
cell
cell
week
period
tumor
growth
observ
grow
approxim
cm
diamet
mice
separ
four
group
contain
six
mice
group
serv
mock
control
group
receiv
mgkg
emodin
group
receiv
mgkg
sb
group
receiv
mgkg
emodin
mgkg
sb
compound
deliv
ip
inject
everi
day
health
mice
tumor
size
monitor
day
treatment
diamet
tumor
measur
calip
two
week
later
mice
sacrif
tumor
excis
weigh
analysi
anim
studi
approv
institut
anim
care
use
committe
iacuc
nation
health
research
institut
taiwan
protocol
nhriiacuc
purpos
screen
effici
dietari
compound
found
emodin
capabl
inhibit
ebv
reactiv
epitheli
cell
repress
express
ebv
lytic
protein
also
block
ebv
viral
particl
product
report
assay
reveal
inhibit
zp
rp
activ
attenu
protein
express
base
great
antiebv
activ
emodin
treatment
inhibit
reactivationelicit
tumorigen
properti
includ
mn
format
cell
prolifer
migrat
matrigel
invas
even
tumor
growth
mice
conclud
emodin
promis
compound
antivir
anticanc
therapi
provid
good
altern
choic
therapi
ebvrel
diseas
malign
